immunoSEQ Blog

Adaptive Customers Publish Latest Results in Journal of Immunology

Screen Shot 2015-03-24 at 4.11.02 PM

A couple weeks ago, a team of researchers from Icahn School of Medicine at Mount Sinai published results from a study in which they used the immunoSEQ assay to examine the effect of two different classes of activating agents (Toll-like receptor (TLR) stimulation versus CD40L/IL21) on B cell memory differentiation and function. The overall conclusion was the… Read More→

Categorized in: Announcements |

Immunology, Seattle, and Biotech Growth from a Rep’s Perspective

From our Southwest Rep Kyle O’Connor… Living in San Diego, I find that I focus on the local business news, often hearing about the strong local biotech or computer technology economy, and not regularly see how other cities and regions are faring during this slow time of economic recovery. It seems that several regions in… Read More→

Context is King

From our Chief Technology Officer, Sean Nolan… Our marketing materials often quote the fact that our database contains billions of unique T- and B-Cell sequences. Seriously, that is an insane number. But in isolation, it can also be misleading. After all, your body pretty much creates sequences at random in its attempt to find ones that work — and… Read More→

Patients Increasingly Willing to Share Health Data to Help Improve Research and Healthcare

From our Product Management Director, Linda Walmer… Hi everyone, I’m a fairly new Product Manager at Adaptive.  My focus is to work with the team, and customers, to create an intuitive and helpful online experience that enables our users to leverage our products and services to their fullest – driving insights and improvements in patient care.  Base… Read More→

Combining Immunotherapies

In December, Nature Publishing Group launched an open access journal called Molecular Therapy – Oncolytics which will focus on the development of biological therapies targeting cancer. Topics will include advancements in therapies such as adoptive T-cells and oncolytic viruses (OVs). One of the initial articles published was a review by Jedd Wolchok and Dmitriy Zamarin making the… Read More→

Categorized in: Food for Thought |

Adaptive and Adaptive Customers Publish Latest Results in Journal of Virology

A couple weeks ago, a team of researchers from Adaptive Biotechnologies, University of Washington, and the Fred Hutchinson Cancer Research Center published results from a study in which they used the immunoSEQ assay to report the identity of activated effector T cell clones that expand in response to the yellow fever vaccine two weeks post-vaccination (as… Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Molecular Immunology

Screen Shot 2015-02-20 at 4.39.14 PM

Last month, a team of researchers from Charles University Prague, University Hospital Motol and General University Hospital in Prague published results from a study in which they used the immunoSEQ assay to profile T and B cell populations in children with Periodic Fever, Aphtous Stomatitis, Pharyngitis, and Adenines (PFAPA) syndrome. The results suggested that the uninhibited, polyclonal response… Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Science Translational Medicine

Screen Shot 2015-02-20 at 4.13.11 PM

Last week, a team of researchers from Columbia University Medical Center, Fred Hutchinson Cancer Research Center, and Massachusetts General Hospital published results from a study in which they used the immunoSEQ assay to examine the TCRB repertoire of patients who underwent a combined kidney and bone marrow transplantation.  The results showed a set of patient-specific T cell… Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Clinical Immunology

Screen Shot 2015-02-18 at 11.34.25 AM

At the beginning of the month, a team of researchers from Montefiore Medical Center, Adaptive Biotechnologies, and Icahn School of Medicine at Mount Sinai recently published results from a study in which they used the immunoSEQ assay to examine the structure and composition of the T cell receptor β chain in Common Variable Immune Deficiency (CVID).  Common Variable… Read More→

Categorized in: Announcements |

Adaptive Customers Publish Latest Results in Transplantation

A team of researchers from Northwestern Memorial Hospital, University of Louisville, and Regenerex recently published results from a study in which they used the immunoSEQ assay to monitor immune reconstitution in patients receiving kidney plus hematopoietic stem cell transplants.  Our assay was able to distinguish the donor immune system from the recipient’s immune system. The abstract is reprinted… Read More→

Categorized in: Announcements |